Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Parkinson's disease. New treatments slow onslaught of symptoms.

Henkel J.

FDA Consum. 1998 Jul-Aug;32(4):13-8. Review. No abstract available.

PMID:
9684562
2.

The effects of deep brain stimulation and levodopa on postural sway in subjects with Parkinson's disease.

Burn DJ.

J Neurol Neurosurg Psychiatry. 2002 Sep;73(3):240. No abstract available.

3.

New hope for Parkinson's disease.

[No authors listed]

Johns Hopkins Med Lett Health After 50. 1998 Oct;10(8):6-7. No abstract available.

PMID:
9766182
4.

Effects of deep brain stimulation and levodopa on postural sway in Parkinson's disease.

Rocchi L, Chiari L, Horak FB.

J Neurol Neurosurg Psychiatry. 2002 Sep;73(3):267-74.

5.

Treating Parkinson's disease.

Standaert D.

Health News. 1998 Nov 20;4(14):1-2. No abstract available.

PMID:
9825707
6.

Subthalamic nucleus stimulation and levodopa-resistant postural instability in Parkinson's disease.

Visser JE, Allum JH, Carpenter MG, Esselink RA, Speelman JD, Borm GF, Bloem BR.

J Neurol. 2008 Feb;255(2):205-10. doi: 10.1007/s00415-008-0636-x.

PMID:
18274810
7.
8.

Parkinson's goal: ease symptoms, slow progression.

[No authors listed]

Johns Hopkins Med Lett Health After 50. 2006 Jun;18(4):4-5. No abstract available.

PMID:
16795901
9.

Parkinson's disease.

DeLong M.

Neurobiol Dis. 2000 Oct;7(5):559-60. No abstract available.

PMID:
11042077
10.

Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease.

Funkiewiez A, Ardouin C, Krack P, Fraix V, Van Blercom N, Xie J, Moro E, Benabid AL, Pollak P.

Mov Disord. 2003 May;18(5):524-30.

PMID:
12722166
11.

[Idiopathic Parkinson's disease].

Vieregge P.

Fortschr Neurol Psychiatr. 2008 Feb;76(2):114-22; quiz 123-6. doi: 10.1055/s-2007-996181. Review. German. No abstract available.

PMID:
18256971
12.

Parkinson's disease. New treatments, still no cure.

[No authors listed]

Mayo Clin Health Lett. 2001 May;19(5):1-3. No abstract available.

PMID:
11349631
13.
14.

Parkinson's disease.

Grayson M.

Nature. 2010 Aug 26;466(7310):S1. doi: 10.1038/466S2a. No abstract available.

PMID:
20739929
15.

Clinical predictive factors of subthalamic stimulation in Parkinson's disease.

Welter ML, Houeto JL, Tezenas du Montcel S, Mesnage V, Bonnet AM, Pillon B, Arnulf I, Pidoux B, Dormont D, Cornu P, Agid Y.

Brain. 2002 Mar;125(Pt 3):575-83.

PMID:
11872614
16.

Effects of nigral stimulation on locomotion and postural stability in patients with Parkinson's disease.

Chastan N, Westby GW, Yelnik J, Bardinet E, Do MC, Agid Y, Welter ML.

Brain. 2009 Jan;132(Pt 1):172-84. doi: 10.1093/brain/awn294.

PMID:
19001482
17.

[5/5. Parkinson disease].

Blond B.

Soins. 2010 Jul-Aug;(747):43-4. French. No abstract available.

PMID:
20799493
18.

Axial parkinsonian symptoms can be improved: the role of levodopa and bilateral subthalamic stimulation.

Bejjani BP, Gervais D, Arnulf I, Papadopoulos S, Demeret S, Bonnet AM, Cornu P, Damier P, Agid Y.

J Neurol Neurosurg Psychiatry. 2000 May;68(5):595-600.

19.

Case studies in the advancement of Parkinson's disease.

Frei K, Truong DD, Wolters E.

CNS Spectr. 2008 Dec;13(12 Suppl 18):1-6.

PMID:
19179948
20.

Ten-Hertz stimulation of subthalamic nucleus deteriorates motor symptoms in Parkinson's disease.

Timmermann L, Wojtecki L, Gross J, Lehrke R, Voges J, Maarouf M, Treuer H, Sturm V, Schnitzler A.

Mov Disord. 2004 Nov;19(11):1328-33.

PMID:
15389990
Items per page

Supplemental Content

Support Center